Toronto, Canada (PRWEB) March 20, 2013
The regulatory environment in Russia changes rapidly – new clinical trial regulations and restrictions are introduced almost every quarter.
Our panel of leading Russian industry and government experts will help you navigate successfully through the sea of changes. Don’t miss this unique opportunity to interact with one of the co-authors of new amendments to the Russian Federal Law on Circulation of Drugs.
This webinar will include three insightful presentations:
Dr. Yuri Afonchikov, Synergy’s VP for Regulatory Affairs, will discuss the Russian regulatory system through the eyes of a European expert
- Dr. Sergei Glagolev, one of the leading experts of the Federal Service on Surveillance in Healthcare (Roszdravnadzor) will discuss biosimiliars, pharmacovigilance and legal amendments in Russia
- Mr. Igor Stefanov, Synergy’s General Manager and a proponent of openness and transparency in the Russian CRO business, will analyze the current state of the clinical trial market in Russia and review the upcoming 2013 trends as well as historical data
For more information about this event or to register, visit: http://xtks.in/xto579-event.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year, thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.
Karen Lim (416) 977-6555 ext 227
Read the full story at http://www.prweb.com/releases/2013/3/prweb10548873.htm.
Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program2
. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy3
. ADVENTRX Announces Establishment of Regulatory Advisory Board4
. Champions Oncology Inc. Receives Approval from U.S. Regulatory Authorities5
. Healthcare, Regulatory and Reimbursement Landscape - Australia6
. Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK7
. Sanguine Appoints Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to Clinical Advisory Board and Ethics Committee8
. RAPS, Eucomed Partner to Provide Online Training to Regulatory Professionals Throughout Europe9
. Webinar on Clinical, Regulatory and Commercialization Strategies for Rare Diseases10
. Webinar to Discuss Biosimilar Regulatory Guidelines in India and Emerging Markets11
. Global Regulatory Milestones for Invibio Biomaterial Solutions